Episode

Bioretec Q1'26: The beginning of the year offered positive signs

Podcast
Inderes
Published
May 18, 2026
Duration seconds
429
Processing state
not_requested
Canonical source
https://podcasters.spotify.com/pod/show/inderes/episodes/Bioretec-Q126-The-beginning-of-the-year-offered-positive-signs-e3jh6oq
Audio
https://anchor.fm/s/8105f970/podcast/play/120150234/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-18%2F424366871-44100-2-6c85d111dfb11.mp3
JSON
/v1/public/podcasts/inderes-6340758/episodes/bioretec-q1-26-the-beginning-of-the-year-offered-positive-signs
Markdown
/podcast/inderes-6340758/bioretec-q1-26-the-beginning-of-the-year-offered-positive-signs.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/inderes-6340758/episodes/bioretec-q1-26-the-beginning-of-the-year-offered-positive-signs/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/inderes-6340758/bioretec-q1-26-the-beginning-of-the-year-offered-positive-signs.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Bioretec's Q1 earnings positively surprised in terms of revenue and profit, particularly due to growth in the US and European markets. Bioretec's CEO, Sarah Hubar-Fisher, tells more about the first quarter in an interview with analyst Antti Siltanen. Topics: 00:00 Introduction 00:15 Positive signs from the beginning of the year 01:41 Drivers behind the numbers 02:39 RemeOs sales 03:08 Orders affecting the comparison period 04:00 Taking RemeOs to China 04:37 Expanding the distributor network 05:35 Recruitment situation 06:30 Operational priorities for the rest of the year